| |
| |
|
| Insider
Information: |
Carter Michael G |
| Relationship: |
Director |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
71,947 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$24,649 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
71,947 |
|
|
| Total
Value |
$24,649 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 158.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncternal Therapeutics Inc |
ONCT |
Director |
2020-09-01 |
71,947 |
2009-07-01 |
0 |
Premium* |
|
|
Santarus Inc |
SNTS |
Director |
2013-03-07 |
0 |
2012-10-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2020-09-01 |
4 |
B |
$2.10 |
$150,001 |
D/D |
71,429 |
71,947 |
2.39 |
% |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2013-03-07 |
4 |
S |
$15.22 |
$487,040 |
D/D |
(32,000) |
0 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2013-01-01 |
4 |
A |
$4.20 |
$2,750 |
D/D |
655 |
36,320 |
0 |
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2012-10-25 |
4 |
OE |
$1.18 |
$37,760 |
D/D |
32,000 |
32,000 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2012-10-01 |
4 |
A |
$4.58 |
$10,125 |
D/D |
2,211 |
35,665 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2012-07-01 |
4 |
A |
$3.52 |
$12,625 |
D/D |
3,587 |
33,454 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2011-10-01 |
4 |
A |
$3.35 |
$8,250 |
D/D |
2,463 |
24,880 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2011-07-01 |
4 |
A |
$4.79 |
$8,250 |
D/D |
1,722 |
22,417 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2011-04-01 |
4 |
A |
$2.57 |
$9,000 |
D/D |
3,502 |
20,695 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2011-01-01 |
4 |
A |
$2.65 |
$9,000 |
D/D |
3,396 |
17,193 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2010-10-01 |
4 |
A |
$3.44 |
$9,000 |
D/D |
2,616 |
13,796 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2010-07-01 |
4 |
A |
$3.05 |
$9,000 |
D/D |
2,951 |
11,180 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2010-04-01 |
4 |
A |
$3.35 |
$9,750 |
D/D |
2,910 |
8,229 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2010-01-01 |
4 |
A |
$4.20 |
$10,500 |
D/D |
2,500 |
5,319 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2009-10-01 |
4 |
A |
$12.80 |
$9,000 |
D/D |
703 |
2,819 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2009-07-01 |
4 |
A |
$9.23 |
$8,250 |
D/D |
894 |
2,116 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2009-04-01 |
4 |
A |
$10.58 |
$9,000 |
D/D |
851 |
1,222 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2009-01-01 |
4 |
A |
$16.84 |
$6,250 |
D/D |
371 |
371 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
